The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Axcella Health Inc | COM | 05454B105 | 23,546 | 7,901,362 | SH | DFND | 2,3 | 0 | 7,901,362 | 0 | |
Axcella Health Inc | COM | 05454B105 | 8,600 | 2,886,023 | SH | DFND | 3,4 | 0 | 2,886,023 | 0 | |
Axcella Health Inc | COM | 05454B105 | 5,248 | 1,761,029 | SH | DFND | 3 | 0 | 1,761,029 | 0 | |
Codiak Biosciences Inc | COM | 192010106 | 34,642 | 2,121,354 | SH | DFND | 1,3 | 0 | 2,121,354 | 0 | |
Codiak Biosciences Inc | COM | 192010106 | 7,936 | 485,949 | SH | DFND | 3 | 0 | 485,949 | 0 | |
Denali Therapeutics Inc | COM | 24823R105 | 137,742 | 2,730,263 | SH | DFND | 1,3 | 0 | 2,730,263 | 0 | |
Evelo Biosciences Inc | COM | 299734103 | 71,845 | 10,205,282 | SH | DFND | 1,3 | 0 | 10,205,282 | 0 | |
Evelo Biosciences Inc | COM | 299734103 | 32,970 | 4,683,213 | SH | DFND | 2,3 | 0 | 4,683,213 | 0 | |
Evelo Biosciences Inc | COM | 299734103 | 29,043 | 4,125,461 | SH | DFND | 3,4 | 0 | 4,125,461 | 0 | |
Evelo Biosciences Inc | COM | 299734103 | 9,648 | 1,370,476 | SH | DFND | 3,6 | 0 | 1,370,476 | 0 | |
Evelo Biosciences Inc | COM | 299734103 | 18,625 | 2,645,637 | SH | DFND | 3 | 0 | 2,645,637 | 0 | |
Foghorn Therapeutics Inc | COM | 344174107 | 129,979 | 9,330,878 | SH | DFND | 1,3 | 0 | 9,330,878 | 0 | |
Foghorn Therapeutics Inc | COM | 344174107 | 20,776 | 1,491,441 | SH | DFND | 3,4 | 0 | 1,491,441 | 0 | |
Foghorn Therapeutics Inc | COM | 344174107 | 25,796 | 1,851,801 | SH | DFND | 3,5 | 0 | 1,851,801 | 0 | |
Kaleido Biosciences Inc | COM | 483347100 | 53,289 | 9,759,979 | SH | DFND | 1,3 | 0 | 9,759,979 | 0 | |
Kaleido Biosciences Inc | COM | 483347100 | 9,437 | 1,728,309 | SH | DFND | 2,3 | 0 | 1,728,309 | 0 | |
Kaleido Biosciences Inc | COM | 483347100 | 16,285 | 2,982,639 | SH | DFND | 3,4 | 0 | 2,982,639 | 0 | |
Kaleido Biosciences Inc | COM | 483347100 | 4,031 | 738,333 | SH | DFND | 3,6 | 0 | 738,333 | 0 | |
Kaleido Biosciences Inc | COM | 483347100 | 23,841 | 4,366,450 | SH | DFND | 3 | 0 | 4,366,450 | 0 | |
Moderna Inc | COM | 60770K107 | 6,764,720 | 17,577,092 | SH | DFND | 2,3 | 0 | 17,577,092 | 0 | |
Moderna Inc | COM | 60770K107 | 1,510 | 3,924 | SH | DFND | 3 | 0 | 3,924 | 0 | |
Omega Therapeutics Inc | COM | 68217N105 | 131,665 | 6,984,856 | SH | DFND | 1,3 | 0 | 6,984,856 | 0 | |
Omega Therapeutics Inc | COM | 68217N105 | 103,952 | 5,514,707 | SH | DFND | 3,5 | 0 | 5,514,707 | 0 | |
Omega Therapeutics Inc | COM | 68217N105 | 18,296 | 970,588 | SH | DFND | 3,6 | 0 | 970,588 | 0 | |
Omega Therapeutics Inc | COM | 68217N105 | 162,438 | 8,617,413 | SH | DFND | 3,7 | 0 | 8,617,413 | 0 | |
Omega Therapeutics Inc | COM | 68217N105 | 71,907 | 3,814,705 | SH | DFND | 3 | 0 | 3,814,705 | 0 | |
Rubius Therapeutics Inc | COM | 78116T103 | 208,281 | 11,648,828 | SH | DFND | 1,3 | 0 | 11,648,828 | 0 | |
Rubius Therapeutics Inc | COM | 78116T103 | 433,125 | 24,223,995 | SH | DFND | 2,3 | 0 | 24,223,995 | 0 | |
Rubius Therapeutics Inc | COM | 78116T103 | 47,091 | 2,633,703 | SH | DFND | 3,4 | 0 | 2,633,703 | 0 | |
Sana Biotechnology Inc | COM | 799566104 | 294,394 | 13,072,570 | SH | DFND | 1,3 | 0 | 13,072,570 | 0 | |
Sana Biotechnology Inc | COM | 799566104 | 219,010 | 9,725,122 | SH | DFND | 3,7 | 0 | 9,725,122 | 0 | |
Sana Biotechnology Inc | COM | 799566104 | 257,659 | 11,441,326 | SH | DFND | 3 | 0 | 11,441,326 | 0 | |
Seres Therapeutics Inc | COM | 81750R102 | 58,832 | 8,452,876 | SH | DFND | 2,3 | 0 | 8,452,876 | 0 | |
Seres Therapeutics Inc | COM | 81750R102 | 20,622 | 2,962,963 | SH | DFND | 3,7 | 0 | 2,962,963 | 0 | |
Seres Therapeutics Inc | COM | 81750R102 | 20,622 | 2,962,963 | SH | DFND | 3,6 | 0 | 2,962,963 | 0 | |
Sigilon Therapeutics Inc | COM | 82657L107 | 50,222 | 8,888,888 | SH | DFND | 1,3 | 0 | 8,888,888 | 0 | |
Sigilon Therapeutics Inc | COM | 82657L107 | 8,370 | 1,481,481 | SH | DFND | 3,5 | 0 | 1,481,481 | 0 | |
Syros Pharmaceuticals Inc | COM | 87184Q107 | 13,135 | 2,938,494 | SH | DFND | 2,3 | 0 | 2,938,494 | 0 |